Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target

Our study highlights the significance of CCL5 in cancer progression and prognosis, particularly in KIRC and ESCA. CCL5's role in modulating the tumor immune microenvironment and its potential as a therapeutic target warrant further investigation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-03-04
DOI
https://doi.org/10.1007/s12672-025-02004-5
Citations
2
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target

Wenming Zhao, Haizhi Qiao, Jirui Sun, Bingjuan Zhou et al.
2 citations
Discover Oncology
Cancer Immunotherapy and Biomarkers
2.09
article

Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target

Wenming Zhao, Haizhi Qiao, Jirui Sun, Bingjuan Zhou, Jinku Zhang
article en
2 citations

Abstract

Our study highlights the significance of CCL5 in cancer progression and prognosis, particularly in KIRC and ESCA. CCL5's role in modulating the tumor immune microenvironment and its potential as a therapeutic target warrant further investigation.

Discover OncologyVol. 16(1)
Baoding People's Hospital (CN)
No poverty
Openalex Percentile: Top 14%
Cancer Immunotherapy and Biomarkers
2.09
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target — Wenming Zhao, Haizhi Qiao, et al. · Discover Oncology (2025) | TGRS Research Map | TGRS